What is the price difference between the original drug and generic drugs of Platinib?

Pralsetinib is a targeted drug mainly used to treat specific types of non-small cell lung cancer (NSCLC). Its mechanism of action is to inhibit tumor growth caused by RET gene mutations. With the promotion of this drug in clinical applications, the price difference between its original drug and generic drugs in domestic and foreign markets has gradually attracted attention. Although the original drug platinib has achieved certain clinical results since it entered the Chinese market, many patients feel pressured by the financial burden because it is not covered by medical insurance.

According to the current market situation, the original drug Platinib is usually available in two specifications: 100mg 60 tablets and 100mg 120 tablets. The price of a single box is generally high, usually more than 20,000 yuan, which can even reach a sky-high price of 60,000 yuan in some areas. This has put many patients who need the drug under huge financial pressure. In this situation, the price of the original drug Platinib overseas is even more shocking. A box of 60 pills can cost almost 40,000 to more than 100,000 yuan. Affected by exchange rate fluctuations, the cost of purchasing the drug for patients is even more difficult to bottom line.

In order to cope with this situation, generic drugs of platinib have also begun to appear on the international market. Recently, the first generic drug of Platinib produced in Laos was approved. Its ingredients are basically the same as the original drug on the market, and its clinical efficacy is similar. The price of this generic drug is about more than 3,000 yuan for 120 capsules. Compared with the original drug, the price is significantly lower. This provides many patients with a more affordable option, allowing more people to benefit from this important anti-cancer drug.

However, despite the obvious price advantages of generic drugs, patients still need to be cautious when choosing. On the one hand, factors such as the production process, quality control and drug stability of generic drugs may be different from the original drugs, thus affecting their therapeutic effects; on the other hand, patients should be guided when taking generic drugs to ensure that they do not affect the development of the disease.

Reference: https://gavreto.com/